Published in

American Association for the Advancement of Science, Science Signaling, 697(14), 2021

DOI: 10.1126/scisignal.aay1027

Links

Tools

Export citation

Search in Google Scholar

Fibrometabolism—An emerging therapeutic frontier in pulmonary fibrosis

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Metabolic reprogramming of myofibroblasts promotes fibrosis and could be targeted to treat fibrotic diseases.